With an eye on expanding its ultrasound direct business into the point-of-care market, medical imaging firm Analogic has inked a deal to purchase ultrasound vendor Ultrasonix Medical for $83 million in cash.
The Canadian ultrasound supplier for point-of-care and general imaging applications has a global installed base of more than 5,000 systems. In a statement announcing the deal, Analogic President and CEO Jim Green highlighted Ultrasonix's ultrasound technology and its complementary direct distribution channel.
The deal enables Analogic to expand its direct ultrasound business into the point-of-care ultrasound market, as well as offer expanded distribution into general imaging in emerging markets, according to Green. The company also believes the acquisition will provide significant revenue and operational synergies, in addition to adding scale to its existing ultrasound business.
For its part, Analogic will offer Ultrasonix advanced technical prowess and access to expanded sales channels, he said.
Ultrasonix had audited 2011 revenue of 34.5 million Canadian ($35 million U.S.), with positive operating income, Analogic said. Analogic expects that the acquisition will be neutral to earnings per share in its 2013 fiscal year, excluding purchase accounting adjustments and transaction-related costs, but accretive in its 2014 fiscal year.
The deal is expected to close in late February.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
